PKC-δ and CaMKII-δ2 mediate ATP-dependent activation of ERK1/2 in vascular smooth muscle

American Journal of Physiology - Cell Physiology

Volumn 286, Issue 6 55-6, 2004, Pages

  Ginnan, Roman ^a   Pfleiderer, Paul J ^a   Pumiglia, Kevin ^a   Singer, Harold A ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

Author keywords

Adenovirus; Calcium calmodulin dependent protein kinase II 2; Epidermal growth factor receptor transactivation; Extracellular signal regulated kinase 1 2; Protein kinase C

Indexed keywords

4 (3 CHLOROANILINO) 6,7 DIMETHOXYQUINAZOLINE; ADENOSINE TRIPHOSPHATE; EPIDERMAL GROWTH FACTOR; IONOMYCIN; MITOGEN ACTIVATED PROTEIN KINASE 1; PHORBOL DIBUTYRATE; PROTEIN KINASE (CALCIUM,CALMODULIN) II; PROTEIN KINASE (CALCIUM,CALMODULIN) II DELTA2; PROTEIN KINASE C; PROTEIN KINASE C DELTA; PROTEIN SERINE THREONINE KINASE; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE INHIBITOR; RAS PROTEIN; ROTTLERIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; ATHEROSCLEROSIS; CELL FUNCTION; CELL PROLIFERATION; CONTROLLED STUDY; DNA SYNTHESIS; EMBRYO DEVELOPMENT; ENZYME ACTIVATION; ENZYME ACTIVITY; INJURY; NONHUMAN; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; RAT; TRANSACTIVATION; VASCULAR SMOOTH MUSCLE;

ADENOSINE TRIPHOSPHATE; ANIMALS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; CELLS, CULTURED; ENZYME INHIBITORS; GENETIC VECTORS; GROWTH SUBSTANCES; ISOENZYMES; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; MUTATION; MYOCYTES, SMOOTH MUSCLE; PROTEIN KINASE C; PROTEIN KINASE C-DELTA; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, EPIDERMAL GROWTH FACTOR; SRC-FAMILY KINASES;

ADENOVIRIDAE; ANIMALIA;

EID: 2442490821     PISSN: 03636143     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpcell.00202.2003     Document Type: Article

References (41)

1. 2+/calmodulin-dependent protein kinase II in the mitogen-activated protein kinase signaling cascade of cultured rat aortic vascular smooth muscle cells. Circ Res 81: 575-584, 1997.
2. Avraham H, Park SY, Schinkmann K, and Avraham S. RAFTK/Pyk2-mediated cellular signalling. Cell Signal 12: 123-133, 2000.
3. Beltman J, McCormick F, and Cook SJ. The selective protein kinase C inhibitor, Ro-31-8220, inhibits mitogen-activated protein kinase phosphatase-1 (MKP-1) expression, induces c-Jun expression, and activates Jun N-terminal kinase. J Biol Chem 271: 27018-27024, 1996.
4. Berk BC. Vascular smooth muscle growth: autocrine growth mechanisms. Physiol Rev 81: 999-1030, 2001.
5. Bornfeldt KE, Campbell JS, Koyama H, Argast GM, Leslie CC, Raines EW, Krebs EG, and Ross R. The mitogen-activated protein kinase pathway can mediate growth inhibition and proliferation in smooth muscle cells. Dependence on the availability of downstream targets. J Clin Invest 100: 875-885, 1997.
6. Burnstock G. Purinergic signaling and vascular cell proliferation and death. Arterioscler Thromb Vasc Biol 22: 364-373, 2002.
7. Busuttil SJ, Morehouse DL, Youkey JR, and Singer HA. Antisense suppresssion of protein kinase C-alpha and -delta in vascular smooth muscle. J Surg Res 63: 137-142, 1996.
8. Carpenter L, Cordery D, and Biden TJ. Inhibition of protein kinase C delta protects rat INS-1 cells against interleukin-1 beta and streptozotocin-induced apoptosis. Diabetes 51: 317-324, 2002.
9. Davies SP, Reddy H, Caivano M, and Cohen P. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 351: 95-105, 2000.
10. Eguchi S, Dempsey PJ, Frank GD, Motley ED, and Inagami T. Activation of MAPKs by angiotensin II in vascular smooth muscle cells. Metalloprotease-dependent EGF receptor activation is required for activation of ERK and p38 MAPK but not for JNK. J Biol Chem 276: 7957-7962, 2001.
11. Eguchi S, Iwasaki H, Inagami T, Numaguchi K, Yamakawa T, Motley ED, Owada KM, Marumo F, and Hirata Y. Involvement of PYK2 in angiotensin II signaling of vascular smooth muscle cells. Hypertension 33: 201-206, 1999.
12. Eguchi S, Iwasaki H, Ueno H, Frank GD, Motley ED, Eguchi K, Marumo F, Hirata Y, and Inagami T. Intracellular signaling of angiotensin II-induced p70 S6 kinase phosphorylation at Ser(411) in vascular smooth muscle cells. Possible requirement of epidermal growth factor receptor, Ras, extracellular signal-regulated kinase, and Akt. J Biol Chem 274: 36843-36851, 1999.
13. Formisano P, Oriente F, Fiory F, Caruso M, Miele C, Maitan MA, Andreozzi F, Vigliotta G, Condorelli G, and Beguinot F. Insulin-activated protein kinase C beta bypasses Ras and stimulates mitogen-activated protein kinase activity and cell proliferation in muscle cells. Mol Cell Biol 20: 6323-6333, 2000.
14. Geisterfer AA, Peach MJ, and Owens GK. Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells. Circ Res 62: 749-756, 1988.
15. Ginnan R and Singer HA. CaM kinase II-dependent activation of tyrosine kinases and ERK1/2 in vascular smooth muscle. Am J Physiol Cell Physiol 282: C754-C761, 2002.
16. 2+. Biochem J 353: 503-512, 2001.
17. Griendling KK, Ushio-Fukai M, Lassegue B, and Alexander RW. Angiotensin II signaling in vascular smooth muscle. New concepts. Hypertension 29: 366-373, 1997.
18. Gschwendt M, Dieterich S, Rennecke J, Kittstein W, Mueller HJ, and Johannes FJ. Inhibition of protein kinase C mu by various inhibitors. Differentiation from protein kinase c isoenzymes. FEBS Lett 392: 77-80, 1996.
19. Gschwendt M, Muller HJ, Kielbassa K, Zang R, Kittstein W, Rincke G, and Marks F. Rottlerin, a novel protein kinase inhibitor. Biochem Biophys Res Commun 199: 93-98, 1994.
20. Hauck CR, Hsia DA, and Schlaepfer DD. Focal adhesion kinase facilitates platelet-derived growth factor-BB-stimulated ERK2 activation required for chemotaxis migration of vascular smooth muscle cells. J Biol Chem 275: 41092-41099, 2000.
21. Heidkamp MC, Bayer AL, Martin JL, and Samarel AM. Differential activation of mitogen-activated protein kinase cascades and apoptosis by protein kinase C epsilon and delta in neonatal rat ventricular myocytes. Circ Res 89: 882-890, 2001.
22. Kalmes A, Daum G, and Clowes AW. EGFR transactivation in the regulation of SMC function. Ann NY Acad Sci 947: 42-54, 2001.
23. Li W, Yu JC, Shin DY, and Pierce JH. Characterization of a protein kinase C-delta (PKC-delta) ATP binding mutant. An inactive enzyme that competitively inhibits wild type PKC-delta enzymatic activity. J Biol Chem 270: 8311-8318, 1995.
24. Li X, Lee JW, Graves LM, and Earp HS. Angiotensin II stimulates ERK via two pathways in epithelial cells: protein kinase C suppresses a G-protein coupled receptor-EGF receptor transactivation pathway. EMBO J 17: 2574-2583, 1998.
25. Marais R, Light Y, Mason C, Paterson H, Olson MF, and Marshall CJ. Requirement of Ras-GTP-Raf complexes for activation of Raf-1 by protein kinase C. Science 280: 109-112, 1998.
26. McNamara CA, Sarembock IJ, Gimple LW, Fenton JW, Coughlin SR, and Owens GK. Thrombin stimulates proliferation of cultured rat aortic smooth muscle cells by a proteolytically activated receptor. J Clin Invest 91: 94-98, 1993.
27. Meadows KN, Bryant P, and Pumiglia K. Vascular endothelial growth factor induction of the angiogenic phenotype requires Ras activation. J Biol Chem 276: 49289-49298, 2001.
28. Newton AC. Protein kinase C: structure, function and regulation. J Biol Chem 270: 28495-28498, 1995.
29. O'Carroll SJ, Hall AR, Myers CJ, Braithwaite AW, and Dix BR. Quantifying adenoviral titers by spectrophotometry. Biotechniques 28: 408-412, 2000.
30. Parsons JT and Parsons SJ. Src family protein tyrosine kinases: cooperating with growth factor and adhesion signaling pathways. Curr Opin Cell Biol 9: 187-192, 1997.
31. 2. Am J Physiol Cell Physiol 286: C1238-C1245, 2004.
32. Pumiglia KM, Le Vine H, Haske T, Habib T, Jove R, and Decker SJ. A direct interaction between G-protein beta gamma subunits and the Raf-1 protein kinase. J Biol Chem 270: 14251-14254, 1995.
33. Robinson MJ and Cobb MH. Mitogen-activated protein kinase pathways. Curr Opin Cell Biol 9: 180-186, 1997.
34. Shah BH and Catt KJ. Calcium-independent activation of extracellularly regulated kinases 1 and 2 by angiotensin II in hepatic C9 cells: roles of protein kinase C delta, Src/proline-rich tyrosine kinase 2, and epidermal growth receptor trans-activation. Mol Pharmacol 61: 343-351, 2002.
35. Singer HA. Protein kinase C. In: Biochemistry of Smooth Muscle Contraction, edited by Bárány M. San Diego, CA: Academic, 1996, p. 155-166.
36. Takahashi T, Kawahara Y, Okuda M, Ueno H, Takeshita A, and Yokoyama M. Angiotensin II stimulates mitogen-activated protein kinases and protein synthesis by a Ras-independent pathway in vascular smooth muscle cells. J Biol Chem 272: 16018-16022, 1997.
37. Ueda Y, Hirai S, Osada S, Suzuki A, Mizuno K, and Ohno S. Protein kinase C activates the MEK-ERK pathway in a manner independent of Ras and dependent on Raf. J Biol Chem 271: 23512-23519, 1996.
38. Van Der Hoeven PC, Van Der Wal JC, Ruurs P, Van Dijk MC, and Van Blitterswijk J. 14-3-3 Isotypes facilitate coupling of protein kinase C-zeta to Raf-1: negative regulation by 14-3-3 phosphorylation. Biochem J 345: 297-306, 2000.
39. 2+/calmodulin-dependent protein kinase II associated with an endoplasmic reticulum stress response in vascular smooth muscle. Mol Cell Biochem 213: 83-92, 2000.
40. Yip-Schneider MT, Miao W, Lin A, Barnard DS, Tzivion G, and Marshall MS. Regulation of the Raf-1 kinase domain by phosphorylation and 14-3-3 association. Biochem J 351: 151-159, 2000.
41. Yoshida K, Miki Y, and Kufe D. Activation of SAPK/JNK signaling by protein kinase C delta in response to DNA damage. J Biol Chem 277: 48372-48378, 2002.